| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
run for pharmaceutical analysts by pharmaceutical analysts
JPAG - PAST MEETINGS
RETURN TO MEETINGS
Thursday 6th February 2020
In silico techniques
Royal Society of Chemistry, London
As the pace of pharmaceutical development accelerates, and organisations look to reduce timelines in all parts of the discovery and development process, opportunities emerge for the greater use of in silico tools to reduce the demand for materials or experimental tests. This meeting will showcase a range of applications of in silico modelling, whether for prediction of properties via first principles modelling, or applying contemporary tools for data-driven modelling. Examples covering chromatography and the physical form of drugs will be discussed, as well as tools for prediction of the key performance properties such as toxicology, dissolution and stability.
Speakers:
Dr Edward Close - Process Systems Enterprise
Prof Mel Euerby - Shimadzu
Dr Andy Maloney - Cambridge Crystallographic Data Centre
Dr James Mann - AstraZeneca
Dr Ed Milton-Harris - ACD/Labs UK
Dr Ghazala Sadiq - Cambridge Crystallographic Data Centre
Dr Garry Scrivens - Pfizer
Dr Patrick Wray - Bristol-Myers Squibb
In silico techniques
Royal Society of Chemistry, London
As the pace of pharmaceutical development accelerates, and organisations look to reduce timelines in all parts of the discovery and development process, opportunities emerge for the greater use of in silico tools to reduce the demand for materials or experimental tests. This meeting will showcase a range of applications of in silico modelling, whether for prediction of properties via first principles modelling, or applying contemporary tools for data-driven modelling. Examples covering chromatography and the physical form of drugs will be discussed, as well as tools for prediction of the key performance properties such as toxicology, dissolution and stability.
Speakers:
Dr Edward Close - Process Systems Enterprise
Prof Mel Euerby - Shimadzu
Dr Andy Maloney - Cambridge Crystallographic Data Centre
Dr James Mann - AstraZeneca
Dr Ed Milton-Harris - ACD/Labs UK
Dr Ghazala Sadiq - Cambridge Crystallographic Data Centre
Dr Garry Scrivens - Pfizer
Dr Patrick Wray - Bristol-Myers Squibb
GET THE REPORT FOR THIS EVENT?
We will send it to you.
We will send it to you.
RETURN TO MEETINGS
WANT TO SEE MORE?
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
PAST MEETINGS
Symposium - October 2011
Delegates at a symposium held at the Royal Pharmaceutical Society
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| © Joint Pharmaceutical Analysis Group 2020 Website by Delta Consultancy Services |
|